Literature DB >> 8168947

Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model.

B E Menzies1, D S Kernodle.   

Abstract

Staphylococcus aureus alpha-toxin is a membrane-damaging exoprotein that oligomerizes to form transmembrane pores. Chemical modification of histidines with diethylpyrocarbonate has been shown to reduce the hemolytic activity of alpha-toxin, suggesting that one or more of the histidine residues is important for toxin function. To individually assess the functional importance of each of the four histidine residues (residues 35, 48, 144, and 259), we used oligonucleotide-directed mutagenesis of the cloned alpha-toxin gene to replace each histidine with leucine. The mutant toxins were expressed in S. aureus and evaluated for hemolytic activity in vitro and for lethality in an intraperitoneal murine model. Substitution of histidine 35 with leucine produced a mutant toxin (H35L) without hemolytic or lethal activity. Mutant toxins H48L, H144L, and H259L exhibited 7, 16, and 46%, respectively, of the hemolytic activity of wild-type toxin. Immunoblotting of purified H35L toxin incubated with liposomal membranes demonstrated intact membrane binding and hexamer formation that was clearly detectable but reduced compared with that of the wild-type toxin. This suggests that hexamer formation alone is not sufficient for the expression of alpha-toxin activity. The nature of the defect underlying the lack of activity of the H35L mutant toxin remains to be elucidated but may involve failure of the hexamer to span the lipid bilayer to form a transmembrane pore or a change in the internal surface and permeability characteristics of the pore.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168947      PMCID: PMC186423          DOI: 10.1128/iai.62.5.1843-1847.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Modification of lysine residues of Staphylococcus aureus alpha-toxin: effects on its channel-forming properties.

Authors:  L Cescatti; C Pederzolli; G Menestrina
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

2.  Staphylococcal alpha-toxin: a study of membrane penetration and pore formation.

Authors:  S Harshman; P Boquet; E Duflot; J E Alouf; C Montecucco; E Papini
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

3.  Preparation and purification of staphylococcal alpha toxin.

Authors:  S Harshman; N Sugg; P Cassidy
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Oligomerization of 3H-labelled staphylococcal alpha-toxin and fragments on adrenocortical Y1 tumour cells.

Authors:  L Blomqvist; M Thelestam
Journal:  Microb Pathog       Date:  1988-03       Impact factor: 3.738

5.  Assay of hemolytic toxins.

Authors:  A W Bernheimer
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

6.  Chemical modification of Staphylococcus aureus alpha-toxin by diethylpyrocarbonate: role of histidines in its membrane-damaging properties.

Authors:  C Pederzolli; L Cescatti; G Menestrina
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

7.  Reaction of staphylococcal alpha-toxin with peptide-induced antibodies.

Authors:  S Harshman; J E Alouf; O Siffert; F Baleux
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

8.  Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes.

Authors:  S Bhakdi; M Muhly; S Korom; F Hugo
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins.

Authors:  M O'Reilly; J C de Azavedo; S Kennedy; T J Foster
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

10.  Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets.

Authors:  S Bhakdi; M Muhly; U Mannhardt; F Hugo; K Klapettek; C Mueller-Eckhardt; L Roka
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  61 in total

1.  Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.

Authors:  Bao Zhong Zhang; Yan Hong Hua; Bin Yu; Candy Choi Yi Lau; Jian Piao Cai; Song Yue Zheng; Wing Cheong Yam; Richard Yi Tsun Kao; Kong Hung Sze; Bo Jian Zheng; Kwok Yung Yuen; Jian Dong Huang
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

Review 2.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

3.  Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury.

Authors:  Georgia A Wilke; Juliane Bubeck Wardenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

4.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

6.  Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Authors:  Santiago M Lattar; Mariángeles Noto Llana; Philippe Denoël; Sophie Germain; Fernanda R Buzzola; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

7.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus.

Authors:  Leon Iri Kupferwasser; Michael R Yeaman; Cynthia C Nast; Deborah Kupferwasser; Yan-Qiong Xiong; Marco Palma; Ambrose L Cheung; Arnold S Bayer
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.

Authors:  Christopher P Mocca; Rebecca A Brady; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

10.  Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.

Authors:  Robin R Craven; Xi Gao; Irving C Allen; Denis Gris; Juliane Bubeck Wardenburg; Erin McElvania-Tekippe; Jenny P Ting; Joseph A Duncan
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.